Tobacco smoking is an important risk factor for the development of severe periodontitis. Recently, we showed that nicotine affected mineralized nodule formation, and that nicotine and lipopolysaccharide stimulated the formation of osteoclast-like cells by increasing production of macrophage colony-stimulating factor (M-CSF) and prostaglandin E 2 (PGE 2 ) by human osteoblastic Saos-2 cells. In the present study, we examined the effects of nicotine on the expression of matrix metalloproteinases (MMPs), tissue inhibitors of matrix metalloproteinases (TIMPs), the plasminogen activation system including the component of tissue-type plasminogen activator (tPA), urokinase-type PA (uPA), and PA inhibitor type 1 (PAI-1), α7 nicotine receptor, and c-fos. We also examined the effect of the nicotine antagonist D-tubocurarine on nicotine-induced expression of MMP-1. Gene expression was examined using real-time polymerase chain reaction (PCR) to estimate mRNA levels. In addition, expression of the MMP, TIMP, uPA, tPA, and PAI-1 proteins was determined by Western blotting analysis. Nicotine treatment caused expression of MMP-1, 2, 3, and 13, but not MMP-14, to increase significantly after 5 or 10 d of culture; MMP-14 expression did not change through day 14. Enhancement of MMP-1 expression by nicotine treatment was eliminated by simultaneous treatment with D-tubocurarine. In the presence of nicotine, expression of uPA, PAI-1, or TIMP-1, 2, 3, or 4 did not change over 14 d of culture, whereas expression of tPA increased significantly by day 7. Nicotine also increased expression of the α7 nicotine receptor and c-fos genes. These results suggest that nicotine stimulates bone matrix turnover by increasing production of tPA and MMP-1, 2, 3, and 13, thereby tipping the balance between bone matrix formation and resorption toward the latter process.
Use of combustible tobacco may be the most important preventable risk factor for accelerated periodontal bone loss [1] . Direct heat from the cigarette, the vasoactive response to nicotine, or one of the many tobacco smoke by-products may be responsible for this fact, but the mechanism by which smoking induces periodontal attachment loss is presently unknown [2−4] . Nicotine has been shown to have detrimental effects on periodontal cells in a variety of ways. In an in vitro study, nicotine inhibited growth of gingival fibroblasts and production of fibronectin and collagen, and promoted collagen breakdown. Nicotineexposed cells exhibited decreased growth and protein content, damaged cell membranes, atypical shapes, and vacuoles [5] . However, the pathogenesis of this process at the molecular level in osteoblasts remains unclear.
Bone resorption involves the simultaneous removal of both inorganic and organic constituents of bone. Dissolution of the mineral phase occurs under the ruffled border membrane of osteoclasts in an acid environment created by the vacuolar-type ATPase, which pumps protons [6] . The proteolytic mechanisms responsible for degrading the organic matrix of bone are less well understood, but may involve lysosomal cysteine proteinases, matrix metalloproteinases (MMPs), or serine proteinases. The MMPs comprise a family of structurally and functionally related proteolytic enzymes that degrade extracellular matrix components such as collagens, elastin, glycoproteins, proteoglycans, and glucosaminoglycans [7] . At least 20 distinct members of the MMP family have been identified thus far, and they have been classified into four subgroups based on substrate specificity [8] . These subgroups are the collagenases (MMP-1, 8, and 13), gelatinases (MMP-2 and 9), membrane-type MMPs (MMP-14, 15, 16, and 17), stromelysins (MMP-3 and 10) and stromelysin-like MMPs (MMP-7, 11, and 12). Conversely, tissue inhibitors of matrix metalloproteinases (TIMPs) are secreted as endogenous inhibitors that down-regulate MMP activity. Four mammalian TIMPs (TIMP-1, 2, 3, and 4) have been cloned and analyzed for their primary structure and function [9, 10] . In the plasminogen/plasmin pathway, generation of plasmin from the precursor zymogen, plasminogen, is induced by two plasminogen activators (PAs), tissue-type PA (tPA) and urokinase-type PA (uPA), and is inhibited by PA inhibitor type-1 (PAI-1) [11, 12] .
Based on the reports that smoking influences the onset and progress of periodontitis [13, 14] , we hypothesized that alveolar bone resorption is greater in smokers than that in non-smokers under the same conditions. This hypothesis is consistent with our previous findings that nicotine inhibits mineralized nodule formation by osteoblasts [15] and that nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing production of macrophage colony-stimulating factor (M-CSF) and prostaglandin E 2 (PGE 2 ) by osteoblasts [16] . However, the effects of nicotine on the proteolytic mechanisms responsible for degrading the organic matrix of bone are unclear. Therefore, we investigated the mechanism by which nicotine promotes osteoblast-mediated degradation of the organic constituents of bone by determining the effect of nicotine on expression of MMP-1, 2, 3, 13, and 14; TIMP-1, 2, 3, and 4; tPA; uPA; PAI-1; α7 nicotine receptor; and c-fos in human osteoblastic Saos-2 cells in vitro. We also examined the effect of the nicotine antagonist D-tubocurarine on nicotine-induced expression of MMP-1.
Materials and Methods

Cell culture
Saos-2 human osteosarcoma cells [17, 18] were obtained from the RIKEN Bioresource Center (Tsukuba, Japan) and used as osteoblasts. The cells were maintained in a growth medium consisting of Dulbecco's modified Eagle medium (DMEM; Gibco BRL, Rockville, USA) containing 10% (V/V) heat-inactivated fetal bovine serum (FBS; HyClone Laboratories, Logan, USA) and 1% (V/V) penicillinstreptomycin solution (Sigma Chemical, St. Louis, USA) at 37 ºC in a humidified atmosphere of 95% air and 5% CO 2 .
For experimental treatment, the cells were seeded onto 100-mm tissue-culture plates at a density of 5×10 , or 10 −3 M nicotine (Wako Fine Chemicals, Osaka, Japan). These nicotine concentrations were chosen based on a previous report by Tipton and Dabbous [19] , who examined the effect of nicotine on the proliferation of human gingival fibroblasts in vitro and on extracellular matrix production by these cells, and on our previous studies that examined the effect of 10 −3 and 10 −4 M nicotine on mineralized nodule formation by Saos-2 cells in vitro [15] , and that examined the effect of 10 −3 M nicotine and 1 or 10 μg/ml lipopolysaccharide on the formation of osteoclast-like cells by increasing M-CSF and PGE 2 production [16] .
The effect of the nicotine antagonist D-tubocurarine (Wako Fine Chemicals) on nicotine-induced changes in MMP-1 expression was examined by adding 10 −3 M Dtubocurarine to the culture medium, as described in previous reports [20] . The cells were cultured with or without 10 −3 M nicotine for up to 14 d.
Real-time PCR
Cells were plated on six-well microplates at a density of 6×10 3 cells/cm 2 and cultured with 0, 10
, or 10 −3 M nicotine for up to 14 d. Total RNA was isolated from the cultured cells on days 3, 5, 7, 10, and 14 using an RNeasy mini kit (Qiagen, Valencia, USA). The mRNA was converted into complementary DNA (cDNA) using an RNA PCR kit (GeneAmp, Perkin-Elmer, Branchburg, USA), and the resulting cDNA mixture was diluted five-fold in sterile distilled water.
Two microliters of the diluted cDNA were subjected to real-time PCR using SYBR Green I dye. All real-time PCR reactions were carried out in triplicate, and the specificity of the PCR products was verified by melting curve analysis. Gene expression levels were normalized by dividing the resulting mRNA values by the value for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA isolated at the same time.
SDS-PAGE and Western blotting
After nicotine treatment, cells were cultured in the absence of nicotine and FBS for an additional 24 h. The culture medium was then collected, dialyzed using a PD-10 column (Amersham Biosciences, Piscataway, USA), and subjected to sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12.5% polyacrylamide gels (8.3 cm×6.5 cm×0.75 mm) with a discontinuous Trisglycine buffer system [21] . Media samples containing 20 μg of extracellular protein were dissolved in 10 μl of sample buffer containing 1% SDS, 2 M urea, 15 mg/ml dithiothreitol, and bromophenol blue, and heated at 95 ºC for 5 min before loading onto the gel. Gels were run at 150 V for 60 min.
Gel-separated proteins were transferred to a membrane using a semi-dry electrotransfer unit with a continuous buffer system consisting of 39 mM glycine, 48 mM Tris, 0.0375% SDS, and 20% (V/V) methanol at a constant amperage of 0.8 mA/cm 2 for 60−90 min. On completion of the transfer, the transfer membrane was treated with 25% (V/V) blocking reagent in Tris-buffered saline (TBS) (10 mM Tris, 145 mM NaCl, pH 7.4) at 4 ºC for 18 h. The sheet was washed in TBS containing Tween-20 (TBSTween) and then incubated at room temperature for 90 min with rabbit polyclonal IgG antibodies (all from Santa Cruz Biotechnology, Santa Cruz, USA) against MMP-1, 2, 3 or 13, tPA (Santa Cruz), or anti-β-tubulin (internal standard) that were diluted 1:200 in distilled water containing 10% (V/V) blocking reagent. The membranes were washed in TBS-Tween and incubated at room temperature for 60 min with appropriate biotin-conjugated secondary antibodies that were diluted 1:10,000 in distilled water containing 10% blocking agent. The membranes were then washed in TBS-Tween and phosphate-buffered saline (PBS, Nissui Pharmaceutical, Tokyo, Japan) and http://www.abbs.info; www.blackwellpublishing.com/abbs then incubated for 30 min at room temperature with horseradish peroxidase-conjugated streptavidin diluted with PBS. Immunoreactive proteins were visualized using a commercial chemiluminescence kit (Amersham Life Science, Buckinghamshire, UK) and autoradiography with X-ray film (Eastman Kodak, New Haven, USA). As a control, membranes were exposed to diluted normal rabbit serum; the dilution factor was the same as that used for the primary antibodies. Pre-stained molecular weight standards that were run on the same gel and transferred were used to estimate protein size.
Statistical analysis
All experiments were performed in triplicate. Each value represents the mean±SD. The significance of differences was determined using Bonferroni's modification of Student's t-test. Differences with P<0.05 were considered significant.
Results
Effect of nicotine on expression of MMP genes
We used real-time PCR to measure expression of the genes encoding MMP-1, 2, 3, 13 and 14 in Saos-2 cells cultured for up to 14 days with 0, 10 −5 , 10 −4 or 10 −3 M nicotine (Fig. 1) . In the absence of nicotine, levels of mRNAs encoding MMP-1, 3 and 13 increased gradually through 14 days of culture. The amount of MMP-2 mRNA increased gradually through day 10, but then decreased on day 14, and the amount of MMP-14 mRNA did not change through day 10 of culture and then increased slightly on day 14.
When Saos-2 cells were cultured with 10 −5 to 10 −3 M nicotine, the amount of MMP-1 mRNA was significantly higher than that in control cells on day 5, 7, 10 and 14. At 10 −4 or 10 −3 M nicotine, mRNA levels for MMP-2 and 3 were also significantly higher than in the control cells. This difference was observed on day 5, 7 and 14 for both MMP-2 and 3, and also on day 10 for MMP-2. For MMP-1, 2 and 3, the increased expression was most evident at 10 −3 M nicotine on day 14. At 10 −3 M nicotine, the level of MMP-13 mRNA expression was significantly higher than that in control cells on day 10 and 14, and this difference was most pronounced on day 14. Nicotine did not appear to affect expression of MMP-14 mRNA.
Effect of nicotine on expression of TIMP genes
We also assessed the effect of nicotine treatment on the , 10 −4 or 10 −3 M nicotine, and levels of TIMP mRNA were analyzed by real-time PCR (Fig. 2) .
In the absence of nicotine, the amount of TIMP-1 mRNA increased gradually through day 10 of culture and decreased slightly on day 14, and the amount of TIMP-2 mRNA increased gradually through day 7 of culture and decreased slightly on day 10. The amount of TIMP-3 mRNA increased gradually through day 7 of culture and decreased on day 10. In contrast, the amount of TIMP-4 mRNA decreased gradually through day 10 of culture and increased slightly on day 14.
Nicotine treatment did not appear to affect expression of TIMP-1, 2, 3 or 4 compared to that in control cells through day 14 of culture.
Effect of nicotine on expression of the tPA, uPA, and PAI-1 genes
Expression of the tPA, uPA, and PAI-1 genes was assessed similarly, using real-time PCR (Fig. 3) . Levels of tPA mRNA increased gradually through 5 days of culture http://www.abbs.info; www.blackwellpublishing.com/abbs in the absence of nicotine and then remained constant from day 7 to 14. In cells treated with 10 −3 M nicotine, expression of tPA mRNA occurred at a significantly higher level than that in control cells on day 7, 10, and 14, and this difference was most pronounced on day 14.
In the absence of nicotine, the amount of uPA mRNA increased gradually through day 5 of culture and decreased slightly on day 7, and the amount of PAI-1 mRNA increased gradually from day 5 to 14. Nicotine treatment did not affect the amount of uPA or PAI-1 mRNA compared with that in control cells through day 14 of culture.
Effect of nicotine on the expression of MMP and tPA proteins
We also examined the effect of nicotine on the expression of tPA and MMP proteins in Saos-2 cells. The cells were cultured for up to 14 days in the presence or absence of 10 −3 M nicotine, and protein levels of tPA and MMP-1, 2, 3, and 13 in the culture media were determined by Western blotting. On day 14 of culture, levels of all five proteins were markedly higher in cells cultured in the presence of nicotine than in the control cells, which is consistent with our results demonstrating that nicotine increases mRNA levels for these proteins (Fig. 4) .
Effect of nicotine on expression of the α7 nicotine receptor and c-fos genes
Expression of the α7 nicotine receptor and c-fos genes in Saos-2 cells cultured for up to 3 d in the presence or absence of 10 −3 M nicotine was determined by real-time PCR. On day 3 of culture, levels of the α7 nicotine receptor and c-fos mRNAs were significantly higher in nicotinetreated cells than in the control cells (Fig. 5) .
Effect of D-tubocurarine on nicotine-induced expression of the MMP-1 gene
The effect of D-tubocurarine on nicotine-induced expression of the MMP-1 gene in Saos-2 cells was examined by real-time PCR. Cells were cultured in the presence of 10 −3 M nicotine, 10 −3 M D-tubocurarine, or both, for up to 14 days. In the absence of D-tubocurarine, nicotine treatment caused the amount of MMP-1 mRNA to increase on day 14 of culture, but simultaneous treatment with D-tubocurarine eliminated this effect on day 14 (Fig. 6) . 
Discussion
Several studies in vitro and in vivo have demonstrated that tobacco smoking is an important risk factor for the development of severe inflammatory periodontal disease. Furthermore, the degree of alveolar bone loss in smokers is reported to be greater than that in nonsmokers [22] . We previously showed that nicotine affects mineralized nodule formation in a simulated mouth environment [15] , and that nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing production of M-CSF and PGE 2 by human osteoblastic Saos-2 cells [16] .
Because the effect of nicotine on the proteolytic mechanisms responsible for the degradation of the organic matrix of bone is not well understood, we examined the effect of nicotine on the expression of MMP-1, 2, 3, 13 and 14 in Saos-2 cells, which we had used previously [15,16,23− 26] . All five of these MMPs are abundant in osteoblasts [27, 28] . We also examined expression of TIMP-1, 2, 3 and 4, uPA, tPA and PAI-1. We chose a treatment period of 14 d, based on our previous research [15, 16] , which examined the effects of nicotine on bone formation and the formation of osteoclast-like cells by Saos-2 cells. In determining the experimental concentration of nicotine, we assumed that nicotine directly stimulates the gingival epithelium; thus, we chose to use concentrations from 10 −5 to 10 −3 M. Our previous studies had already shown that 10 −3 M nicotine does not kill Saos-2 cells [15, 16] . Type I collagen is a major organic constituent of the extracellular matrix of bone. Of the non-collagenous bone matrix proteins, the major proteins include the chondroitin sulfate-type small proteoglycans, bone sialoprotein, osteopontin, osteocalcin, and SPARC/osteonectin [29] . MMP-1 and 13 cleave type I collagen, the most abundant protein present in the osteoid layer, into characteristic 3:1 length fragments, which subsequently denature into random-coil polypeptide chains at physiological temperature [30] . Digestion of type I collagen by MMP-1 and 13 thus appears to be the initial step in the bone resorption process. Subsequently, denatured collagen fragments can be degraded further by MMP-2. MMP-13 has broad substrate specificity [31] and may cleave other bone matrix proteins such as proteoglycans, glycoproteins, and native type IV and IX collagens in the osteoid layer.
Posttranslational regulation of MMP activity depends on the interactions between MMPs and inhibitory TIMPs [30] . MMPs are secreted as latent, inactive proenzymes that are activated by the sequential cleavage of their N-terminal propeptide by other proteinases. Pro-MMP-13 is reportedly activated by MMP-2 and 14 [32] , as well as by MMP-3 and plasmin [30] . In a reaction dependent on TIMP-2 binding, the membrane gelatinase MMP-14 activates pro-MMP-2 and pro-MMP-13 to produce MMP-2 and MMP-13 derivatives of decreasing molecular size, increasing molar enzymatic activity, and reduced the efficiency of binding to tissue inhibitors [33] . TIMP-3, unlike TIMP-1 and 2, binds to the extracellular matrix [34] , and TIMP-4, the most recently discovered member of the TIMP family, blocks the activities of several MMPs implicated in arthritic cartilage erosion [35] .
In light of these findings, we examined the effect of nicotine on the expression of MMPs and TIMPs in Saos-2 cells. Expression of MMP-1, 2, 3 and 13 increased significantly after day 5 or 10 of culture in the presence of nicotine, whereas nicotine did not affect MMP-14 expression over 14 days in culture. Nicotine induction of MMP-1 expression was blocked by simultaneous treatment with D-tubocurarine, showing that the effect was nicotinespecific. In contrast to the generally enhancing effect of nicotine on MMP expression, nicotine had no effect on the expression of TIMPs over 14 days in culture. Similar results were obtained using another osteoblastic cell line, the rat clonal line ROS 17/2.8 [36] (data not shown). These results indicate that nicotine may tip the balance between the actions of MMPs and TIMPs toward the breakdown of bone matrix proteins.
In the plasminogen/plasmin system, the inactive proenzyme plasminogen is converted to the proteolytic enzyme plasmin by two physiological PAs, tPA and uPA [11] . Plasmin is a broad-spectrum serine protease that can degrade several noncollagenous components of the extracellular matrix, including fibronectin, laminin, and the core protein of proteoglycans [37] . In addition, plasmin has been reported to cleave osteocalcin and release it from hydroxyapatite [38] . Plasmin may also participate indirectly in collagen breakdown by activating latent MMPs [39, 40] .
Fibrinolysis may be inhibited at the plasmin level (primarily by α2-antiplasmin) or at the PA level. Inhibition of PAs is mediated by specific PAIs, principally PAI-1 [41] . Removal of fibrin from the vascular tree is believed to be carried out primarily by tPA, owing to the high specific affinity of tPA for fibrin [11] . On the other hand, uPA binds to a cellular receptor and may participate in pericellular proteolysis by degrading matrix components or by activating latent proteinases or growth factors [12] . Taken together, these data suggest that plasmin modulates degradation of the osteoid layer covering the bone surface; since it exposes resorption-stimulating minerals to the osteoclasts, this degradation may initiate the bone http://www.abbs.info; www.blackwellpublishing.com/abbs resorption process [37, 42] .
Given these findings, we also examined the effect of nicotine on PA and PAI-1 expression. In nicotine-treated Saos-2 cells, expression of tPA increased significantly after 7 days of culture, whereas expression of uPA and PAI-1 did not change through 14 days of culture, suggesting that nicotine stimulates tPA production in osteoblasts. Furthermore, nicotine-induced tPA expression may activate pro-MMPs by increasing production of plasmin, which degrades noncollagenous matrix proteins in the bone extracellular matrix.
Confirmation that the observed changes in mRNA and protein expression were specific to nicotine stimulation is provided by two sets of results. First, we found that nicotine treatment caused a significant increase in expression of the genes encoding the α2 nicotine receptor [43] and the c-fos transcription factor [20] . Second, the nicotine antagonist D-tubocurarine [20] blocked the enhancement of MMP-1 gene expression by nicotine. Taken together, the results of this study suggest that nicotine stimulates turnover of the bone matrix by increasing production of MMP-1, 2, 3 and 13 and tPA in osteoblasts, which tips the balance between bone production and resorption toward the latter process. Degradation of bone matrix proteins by these enzymes in osteoblasts may promote the resorption of alveolar bone in the mouth of smokers.
